entg-20230701
false2023Q2ENTEGRIS INC0001101302--12-3100011013022023-01-012023-07-0100011013022023-07-31xbrli:shares00011013022023-07-01iso4217:USD00011013022022-12-31iso4217:USDxbrli:shares00011013022023-04-022023-07-0100011013022022-04-032022-07-0200011013022022-01-012022-07-0200011013022022-01-012022-10-010001101302us-gaap:CommonStockMember2021-12-310001101302us-gaap:TreasuryStockCommonMember2021-12-310001101302us-gaap:AdditionalPaidInCapitalMember2021-12-310001101302us-gaap:RetainedEarningsMember2021-12-310001101302us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-12-310001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-3100011013022021-12-310001101302us-gaap:CommonStockMember2022-01-012022-04-020001101302us-gaap:TreasuryStockCommonMember2022-01-012022-04-020001101302us-gaap:AdditionalPaidInCapitalMember2022-01-012022-04-020001101302us-gaap:RetainedEarningsMember2022-01-012022-04-020001101302us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-04-020001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-012022-04-020001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-04-0200011013022022-01-012022-04-020001101302us-gaap:CommonStockMember2022-04-020001101302us-gaap:TreasuryStockCommonMember2022-04-020001101302us-gaap:AdditionalPaidInCapitalMember2022-04-020001101302us-gaap:RetainedEarningsMember2022-04-020001101302us-gaap:AccumulatedTranslationAdjustmentMember2022-04-020001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-04-020001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-0200011013022022-04-020001101302us-gaap:CommonStockMember2022-04-032022-07-020001101302us-gaap:TreasuryStockCommonMember2022-04-032022-07-020001101302us-gaap:AdditionalPaidInCapitalMember2022-04-032022-07-020001101302us-gaap:RetainedEarningsMember2022-04-032022-07-020001101302us-gaap:AccumulatedTranslationAdjustmentMember2022-04-032022-07-020001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-04-032022-07-020001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-032022-07-020001101302us-gaap:CommonStockMember2022-07-020001101302us-gaap:TreasuryStockCommonMember2022-07-020001101302us-gaap:AdditionalPaidInCapitalMember2022-07-020001101302us-gaap:RetainedEarningsMember2022-07-020001101302us-gaap:AccumulatedTranslationAdjustmentMember2022-07-020001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-07-020001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-0200011013022022-07-020001101302us-gaap:CommonStockMember2022-12-310001101302us-gaap:TreasuryStockCommonMember2022-12-310001101302us-gaap:AdditionalPaidInCapitalMember2022-12-310001101302us-gaap:RetainedEarningsMember2022-12-310001101302us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310001101302us-gaap:CommonStockMember2023-01-012023-04-010001101302us-gaap:TreasuryStockCommonMember2023-01-012023-04-010001101302us-gaap:AdditionalPaidInCapitalMember2023-01-012023-04-010001101302us-gaap:RetainedEarningsMember2023-01-012023-04-010001101302us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-04-010001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-04-010001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-04-0100011013022023-01-012023-04-010001101302us-gaap:CommonStockMember2023-04-010001101302us-gaap:TreasuryStockCommonMember2023-04-010001101302us-gaap:AdditionalPaidInCapitalMember2023-04-010001101302us-gaap:RetainedEarningsMember2023-04-010001101302us-gaap:AccumulatedTranslationAdjustmentMember2023-04-010001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-04-010001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-04-0100011013022023-04-010001101302us-gaap:CommonStockMember2023-04-022023-07-010001101302us-gaap:TreasuryStockCommonMember2023-04-022023-07-010001101302us-gaap:AdditionalPaidInCapitalMember2023-04-022023-07-010001101302us-gaap:RetainedEarningsMember2023-04-022023-07-010001101302us-gaap:AccumulatedTranslationAdjustmentMember2023-04-022023-07-010001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-04-022023-07-010001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-04-022023-07-010001101302us-gaap:CommonStockMember2023-07-010001101302us-gaap:TreasuryStockCommonMember2023-07-010001101302us-gaap:AdditionalPaidInCapitalMember2023-07-010001101302us-gaap:RetainedEarningsMember2023-07-010001101302us-gaap:AccumulatedTranslationAdjustmentMember2023-07-010001101302us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-010001101302us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-07-0100011013022022-07-062022-07-060001101302entg:CMCMaterialsMember2023-01-012023-04-010001101302entg:CMCMaterialsMember2023-01-012023-07-010001101302entg:CMCMaterialsMember2022-07-062022-07-060001101302entg:CMCMaterialsMember2022-07-060001101302us-gaap:SecuredDebtMember2022-07-060001101302entg:SeniorSecuredNotesDue2029Member2022-07-060001101302entg:SeniorUnsecuredNotesDue2030Member2022-07-060001101302us-gaap:BridgeLoanMember2022-07-0600011013022022-07-060001101302entg:CMCMaterialsMemberus-gaap:DevelopedTechnologyRightsMember2022-07-060001101302entg:CMCMaterialsMemberus-gaap:DevelopedTechnologyRightsMember2022-07-062022-07-060001101302entg:CMCMaterialsMemberus-gaap:TrademarksAndTradeNamesMember2022-07-060001101302entg:CMCMaterialsMemberus-gaap:TrademarksAndTradeNamesMember2022-07-062022-07-060001101302entg:CMCMaterialsMemberus-gaap:CustomerRelationshipsMember2022-07-060001101302entg:CMCMaterialsMemberus-gaap:CustomerRelationshipsMember2022-07-062022-07-060001101302entg:CMCMaterialsMemberus-gaap:InProcessResearchAndDevelopmentMember2022-07-060001101302entg:CMCMaterialsMemberus-gaap:InProcessResearchAndDevelopmentMember2022-07-062022-07-060001101302us-gaap:OtherIntangibleAssetsMemberentg:CMCMaterialsMember2022-07-060001101302us-gaap:OtherIntangibleAssetsMemberentg:CMCMaterialsMember2022-07-062022-07-0600011013022023-02-102023-02-100001101302entg:PIMMember2023-02-102023-02-100001101302entg:PIMMember2023-01-012023-07-010001101302entg:PIMMember2023-07-010001101302entg:PIMMember2023-04-022023-07-010001101302entg:ECMember2023-04-022023-07-010001101302entg:ECMember2023-01-012023-07-010001101302entg:ECMember2023-07-010001101302entg:ECMember2023-05-102023-05-100001101302entg:QEDMember2023-01-012023-07-010001101302entg:QEDMember2023-03-102023-03-1000011013022023-03-102023-03-100001101302entg:QEDMember2023-03-100001101302entg:QEDMember2023-07-0100011013022023-06-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2022-12-310001101302entg:AdvancedPlanarizationSolutionsMember2022-12-310001101302entg:MicrocontaminationControlMember2022-12-310001101302entg:AdvancedMaterialsHandlingAMHMember2022-12-310001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2023-07-010001101302entg:AdvancedPlanarizationSolutionsMember2023-07-010001101302entg:MicrocontaminationControlMember2023-07-010001101302entg:AdvancedMaterialsHandlingAMHMember2023-07-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2023-01-012023-07-010001101302entg:AdvancedPlanarizationSolutionsMember2023-01-012023-07-010001101302entg:MicrocontaminationControlMember2023-01-012023-07-010001101302entg:AdvancedMaterialsHandlingAMHMember2023-01-012023-07-0100011013022023-07-012023-07-010001101302us-gaap:DevelopedTechnologyRightsMember2023-07-010001101302us-gaap:TrademarksAndTradeNamesMember2023-07-010001101302us-gaap:CustomerRelationshipsMember2023-07-010001101302us-gaap:InProcessResearchAndDevelopmentMember2023-07-010001101302us-gaap:OtherIntangibleAssetsMember2023-07-010001101302us-gaap:DevelopedTechnologyRightsMember2022-12-310001101302us-gaap:TrademarksAndTradeNamesMember2022-12-310001101302us-gaap:CustomerRelationshipsMember2022-12-310001101302us-gaap:InProcessResearchAndDevelopmentMember2022-12-310001101302us-gaap:OtherIntangibleAssetsMember2022-12-310001101302entg:SecuredDebtDue2029Member2023-07-010001101302entg:SecuredDebtDue2029Member2022-12-310001101302entg:SeniorSecuredNotesDue2029Member2023-07-010001101302entg:SeniorSecuredNotesDue2029Member2022-12-310001101302entg:SeniorUnsecuredNotesDue2030Member2023-07-010001101302entg:SeniorUnsecuredNotesDue2030Member2022-12-310001101302entg:SeniorUnsecuredNotesDue2029Member2023-07-010001101302entg:SeniorUnsecuredNotesDue2029Member2022-12-310001101302entg:SeniorUnsecuredNotesDue2028Member2023-07-010001101302entg:SeniorUnsecuredNotesDue2028Member2022-12-310001101302us-gaap:BridgeLoanMember2023-07-010001101302us-gaap:BridgeLoanMember2022-12-310001101302us-gaap:LongTermDebtMember2023-07-010001101302us-gaap:LongTermDebtMember2022-12-310001101302us-gaap:SecuredDebtMember2023-07-01xbrli:pure0001101302us-gaap:SecuredDebtMember2023-04-022023-07-010001101302entg:SecuredDebtDue2029Member2023-04-022023-07-010001101302entg:SecuredDebtDue2029Member2023-01-012023-07-0100011013022023-04-202023-04-200001101302us-gaap:FairValueInputsLevel1Member2023-07-010001101302us-gaap:FairValueInputsLevel1Member2022-12-310001101302us-gaap:FairValueInputsLevel2Member2023-07-010001101302us-gaap:FairValueInputsLevel2Member2022-12-310001101302us-gaap:FairValueInputsLevel3Member2023-07-010001101302us-gaap:FairValueInputsLevel3Member2022-12-310001101302us-gaap:FairValueInputsLevel12And3Member2023-07-010001101302us-gaap:FairValueInputsLevel12And3Member2022-12-310001101302us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMember2023-07-010001101302us-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMember2022-12-310001101302us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2023-07-010001101302us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMember2023-07-010001101302us-gaap:FairValueInputsLevel3Memberus-gaap:InterestRateSwapMember2022-12-310001101302us-gaap:FairValueInputsLevel12And3Memberus-gaap:InterestRateSwapMember2023-07-010001101302us-gaap:FairValueInputsLevel12And3Memberus-gaap:InterestRateSwapMember2022-12-310001101302us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMember2022-12-310001101302us-gaap:FairValueInputsLevel12And3Memberus-gaap:ForeignExchangeContractMember2022-12-310001101302us-gaap:NondesignatedMemberus-gaap:LongMemberus-gaap:ForeignExchangeContractMember2023-07-010001101302us-gaap:NondesignatedMemberus-gaap:LongMemberus-gaap:ForeignExchangeContractMember2022-12-310001101302us-gaap:ShortMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-07-010001101302us-gaap:ShortMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-12-310001101302us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2023-07-010001101302us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2022-12-310001101302us-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-010001101302us-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001101302us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2023-07-010001101302us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2022-12-310001101302us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMember2023-07-010001101302us-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeContractMember2022-12-310001101302us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-04-022023-07-010001101302us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-04-032022-07-020001101302us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-07-010001101302us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-07-020001101302us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-04-022023-07-010001101302us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-04-032022-07-020001101302us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2023-01-012023-07-010001101302us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2022-01-012022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2023-04-022023-07-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2022-04-032022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2022-01-012022-07-020001101302entg:AdvancedPlanarizationSolutionsMember2023-04-022023-07-010001101302entg:AdvancedPlanarizationSolutionsMember2022-04-032022-07-020001101302entg:AdvancedPlanarizationSolutionsMember2022-01-012022-07-020001101302entg:MicrocontaminationControlMember2023-04-022023-07-010001101302entg:MicrocontaminationControlMember2022-04-032022-07-020001101302entg:MicrocontaminationControlMember2022-01-012022-07-020001101302entg:AdvancedMaterialsHandlingAMHMember2023-04-022023-07-010001101302entg:AdvancedMaterialsHandlingAMHMember2022-04-032022-07-020001101302entg:AdvancedMaterialsHandlingAMHMember2022-01-012022-07-020001101302entg:IntersegmentSalesEliminationMember2023-04-022023-07-010001101302entg:IntersegmentSalesEliminationMember2022-04-032022-07-020001101302entg:IntersegmentSalesEliminationMember2023-01-012023-07-010001101302entg:IntersegmentSalesEliminationMember2022-01-012022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:US2023-04-022023-07-010001101302entg:AdvancedPlanarizationSolutionsMembercountry:US2023-04-022023-07-010001101302entg:MicrocontaminationControlMembercountry:US2023-04-022023-07-010001101302country:USentg:AdvancedMaterialsHandlingAMHMember2023-04-022023-07-010001101302entg:IntersegmentSalesEliminationMembercountry:US2023-04-022023-07-010001101302country:US2023-04-022023-07-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:TW2023-04-022023-07-010001101302entg:AdvancedPlanarizationSolutionsMembercountry:TW2023-04-022023-07-010001101302entg:MicrocontaminationControlMembercountry:TW2023-04-022023-07-010001101302country:TWentg:AdvancedMaterialsHandlingAMHMember2023-04-022023-07-010001101302entg:IntersegmentSalesEliminationMembercountry:TW2023-04-022023-07-010001101302country:TW2023-04-022023-07-010001101302country:CNentg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2023-04-022023-07-010001101302country:CNentg:AdvancedPlanarizationSolutionsMember2023-04-022023-07-010001101302entg:MicrocontaminationControlMembercountry:CN2023-04-022023-07-010001101302country:CNentg:AdvancedMaterialsHandlingAMHMember2023-04-022023-07-010001101302entg:IntersegmentSalesEliminationMembercountry:CN2023-04-022023-07-010001101302country:CN2023-04-022023-07-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:KR2023-04-022023-07-010001101302entg:AdvancedPlanarizationSolutionsMembercountry:KR2023-04-022023-07-010001101302entg:MicrocontaminationControlMembercountry:KR2023-04-022023-07-010001101302country:KRentg:AdvancedMaterialsHandlingAMHMember2023-04-022023-07-010001101302entg:IntersegmentSalesEliminationMembercountry:KR2023-04-022023-07-010001101302country:KR2023-04-022023-07-010001101302country:JPentg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2023-04-022023-07-010001101302country:JPentg:AdvancedPlanarizationSolutionsMember2023-04-022023-07-010001101302country:JPentg:MicrocontaminationControlMember2023-04-022023-07-010001101302country:JPentg:AdvancedMaterialsHandlingAMHMember2023-04-022023-07-010001101302country:JPentg:IntersegmentSalesEliminationMember2023-04-022023-07-010001101302country:JP2023-04-022023-07-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembersrt:EuropeMember2023-04-022023-07-010001101302entg:AdvancedPlanarizationSolutionsMembersrt:EuropeMember2023-04-022023-07-010001101302entg:MicrocontaminationControlMembersrt:EuropeMember2023-04-022023-07-010001101302srt:EuropeMemberentg:AdvancedMaterialsHandlingAMHMember2023-04-022023-07-010001101302entg:IntersegmentSalesEliminationMembersrt:EuropeMember2023-04-022023-07-010001101302srt:EuropeMember2023-04-022023-07-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMemberentg:SoutheastAsiaMember2023-04-022023-07-010001101302entg:AdvancedPlanarizationSolutionsMemberentg:SoutheastAsiaMember2023-04-022023-07-010001101302entg:MicrocontaminationControlMemberentg:SoutheastAsiaMember2023-04-022023-07-010001101302entg:SoutheastAsiaMemberentg:AdvancedMaterialsHandlingAMHMember2023-04-022023-07-010001101302entg:IntersegmentSalesEliminationMemberentg:SoutheastAsiaMember2023-04-022023-07-010001101302entg:SoutheastAsiaMember2023-04-022023-07-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:US2022-04-032022-07-020001101302entg:AdvancedPlanarizationSolutionsMembercountry:US2022-04-032022-07-020001101302entg:MicrocontaminationControlMembercountry:US2022-04-032022-07-020001101302country:USentg:AdvancedMaterialsHandlingAMHMember2022-04-032022-07-020001101302entg:IntersegmentSalesEliminationMembercountry:US2022-04-032022-07-020001101302country:US2022-04-032022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:TW2022-04-032022-07-020001101302entg:AdvancedPlanarizationSolutionsMembercountry:TW2022-04-032022-07-020001101302entg:MicrocontaminationControlMembercountry:TW2022-04-032022-07-020001101302country:TWentg:AdvancedMaterialsHandlingAMHMember2022-04-032022-07-020001101302entg:IntersegmentSalesEliminationMembercountry:TW2022-04-032022-07-020001101302country:TW2022-04-032022-07-020001101302country:CNentg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2022-04-032022-07-020001101302country:CNentg:AdvancedPlanarizationSolutionsMember2022-04-032022-07-020001101302entg:MicrocontaminationControlMembercountry:CN2022-04-032022-07-020001101302country:CNentg:AdvancedMaterialsHandlingAMHMember2022-04-032022-07-020001101302entg:IntersegmentSalesEliminationMembercountry:CN2022-04-032022-07-020001101302country:CN2022-04-032022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:KR2022-04-032022-07-020001101302entg:AdvancedPlanarizationSolutionsMembercountry:KR2022-04-032022-07-020001101302entg:MicrocontaminationControlMembercountry:KR2022-04-032022-07-020001101302country:KRentg:AdvancedMaterialsHandlingAMHMember2022-04-032022-07-020001101302entg:IntersegmentSalesEliminationMembercountry:KR2022-04-032022-07-020001101302country:KR2022-04-032022-07-020001101302country:JPentg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2022-04-032022-07-020001101302country:JPentg:AdvancedPlanarizationSolutionsMember2022-04-032022-07-020001101302country:JPentg:MicrocontaminationControlMember2022-04-032022-07-020001101302country:JPentg:AdvancedMaterialsHandlingAMHMember2022-04-032022-07-020001101302country:JPentg:IntersegmentSalesEliminationMember2022-04-032022-07-020001101302country:JP2022-04-032022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembersrt:EuropeMember2022-04-032022-07-020001101302entg:AdvancedPlanarizationSolutionsMembersrt:EuropeMember2022-04-032022-07-020001101302entg:MicrocontaminationControlMembersrt:EuropeMember2022-04-032022-07-020001101302srt:EuropeMemberentg:AdvancedMaterialsHandlingAMHMember2022-04-032022-07-020001101302entg:IntersegmentSalesEliminationMembersrt:EuropeMember2022-04-032022-07-020001101302srt:EuropeMember2022-04-032022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMemberentg:SoutheastAsiaMember2022-04-032022-07-020001101302entg:AdvancedPlanarizationSolutionsMemberentg:SoutheastAsiaMember2022-04-032022-07-020001101302entg:MicrocontaminationControlMemberentg:SoutheastAsiaMember2022-04-032022-07-020001101302entg:SoutheastAsiaMemberentg:AdvancedMaterialsHandlingAMHMember2022-04-032022-07-020001101302entg:IntersegmentSalesEliminationMemberentg:SoutheastAsiaMember2022-04-032022-07-020001101302entg:SoutheastAsiaMember2022-04-032022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:US2023-01-012023-07-010001101302entg:AdvancedPlanarizationSolutionsMembercountry:US2023-01-012023-07-010001101302entg:MicrocontaminationControlMembercountry:US2023-01-012023-07-010001101302country:USentg:AdvancedMaterialsHandlingAMHMember2023-01-012023-07-010001101302entg:IntersegmentSalesEliminationMembercountry:US2023-01-012023-07-010001101302country:US2023-01-012023-07-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:TW2023-01-012023-07-010001101302entg:AdvancedPlanarizationSolutionsMembercountry:TW2023-01-012023-07-010001101302entg:MicrocontaminationControlMembercountry:TW2023-01-012023-07-010001101302country:TWentg:AdvancedMaterialsHandlingAMHMember2023-01-012023-07-010001101302country:TW2023-01-012023-07-010001101302country:CNentg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2023-01-012023-07-010001101302country:CNentg:AdvancedPlanarizationSolutionsMember2023-01-012023-07-010001101302entg:MicrocontaminationControlMembercountry:CN2023-01-012023-07-010001101302country:CNentg:AdvancedMaterialsHandlingAMHMember2023-01-012023-07-010001101302country:CN2023-01-012023-07-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:KR2023-01-012023-07-010001101302entg:AdvancedPlanarizationSolutionsMembercountry:KR2023-01-012023-07-010001101302entg:MicrocontaminationControlMembercountry:KR2023-01-012023-07-010001101302country:KRentg:AdvancedMaterialsHandlingAMHMember2023-01-012023-07-010001101302country:KR2023-01-012023-07-010001101302country:JPentg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2023-01-012023-07-010001101302country:JPentg:AdvancedPlanarizationSolutionsMember2023-01-012023-07-010001101302country:JPentg:MicrocontaminationControlMember2023-01-012023-07-010001101302country:JPentg:AdvancedMaterialsHandlingAMHMember2023-01-012023-07-010001101302country:JP2023-01-012023-07-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembersrt:EuropeMember2023-01-012023-07-010001101302entg:AdvancedPlanarizationSolutionsMembersrt:EuropeMember2023-01-012023-07-010001101302entg:MicrocontaminationControlMembersrt:EuropeMember2023-01-012023-07-010001101302srt:EuropeMemberentg:AdvancedMaterialsHandlingAMHMember2023-01-012023-07-010001101302srt:EuropeMember2023-01-012023-07-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMemberentg:SoutheastAsiaMember2023-01-012023-07-010001101302entg:AdvancedPlanarizationSolutionsMemberentg:SoutheastAsiaMember2023-01-012023-07-010001101302entg:MicrocontaminationControlMemberentg:SoutheastAsiaMember2023-01-012023-07-010001101302entg:SoutheastAsiaMemberentg:AdvancedMaterialsHandlingAMHMember2023-01-012023-07-010001101302entg:SoutheastAsiaMember2023-01-012023-07-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:US2022-01-012022-10-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:US2022-01-012022-07-020001101302entg:AdvancedPlanarizationSolutionsMembercountry:US2022-01-012022-07-020001101302entg:AdvancedPlanarizationSolutionsMembercountry:US2022-01-012022-10-010001101302entg:MicrocontaminationControlMembercountry:US2022-01-012022-07-020001101302entg:MicrocontaminationControlMembercountry:US2022-01-012022-10-010001101302country:USentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-07-020001101302country:USentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-10-010001101302entg:IntersegmentSalesEliminationMembercountry:US2022-01-012022-07-020001101302entg:IntersegmentSalesEliminationMembercountry:US2022-01-012022-10-010001101302country:US2022-01-012022-10-010001101302country:US2022-01-012022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:TW2022-01-012022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:TW2022-01-012022-10-010001101302entg:AdvancedPlanarizationSolutionsMembercountry:TW2022-01-012022-10-010001101302entg:AdvancedPlanarizationSolutionsMembercountry:TW2022-01-012022-07-020001101302entg:MicrocontaminationControlMembercountry:TW2022-01-012022-07-020001101302entg:MicrocontaminationControlMembercountry:TW2022-01-012022-10-010001101302country:TWentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-10-010001101302country:TWentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-07-020001101302entg:IntersegmentSalesEliminationMembercountry:TW2022-01-012022-10-010001101302country:TW2022-01-012022-10-010001101302country:TW2022-01-012022-07-020001101302country:CNentg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2022-01-012022-07-020001101302country:CNentg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2022-01-012022-10-010001101302country:CNentg:AdvancedPlanarizationSolutionsMember2022-01-012022-07-020001101302country:CNentg:AdvancedPlanarizationSolutionsMember2022-01-012022-10-010001101302entg:MicrocontaminationControlMembercountry:CN2022-01-012022-07-020001101302entg:MicrocontaminationControlMembercountry:CN2022-01-012022-10-010001101302country:CNentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-07-020001101302country:CNentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-10-010001101302entg:IntersegmentSalesEliminationMembercountry:CN2022-01-012022-10-010001101302country:CN2022-01-012022-10-010001101302country:CN2022-01-012022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:KR2022-01-012022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembercountry:KR2022-01-012022-10-010001101302entg:AdvancedPlanarizationSolutionsMembercountry:KR2022-01-012022-07-020001101302entg:AdvancedPlanarizationSolutionsMembercountry:KR2022-01-012022-10-010001101302country:KRentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-10-010001101302entg:MicrocontaminationControlMembercountry:KR2022-01-012022-07-020001101302entg:MicrocontaminationControlMembercountry:KR2022-01-012022-10-010001101302country:KRentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-07-020001101302entg:IntersegmentSalesEliminationMembercountry:KR2022-01-012022-10-010001101302country:KR2022-01-012022-07-020001101302country:KR2022-01-012022-10-010001101302country:JPentg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2022-01-012022-10-010001101302country:JPentg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2022-01-012022-07-020001101302country:JPentg:AdvancedPlanarizationSolutionsMember2022-01-012022-07-020001101302country:JPentg:AdvancedPlanarizationSolutionsMember2022-01-012022-10-010001101302country:JPentg:MicrocontaminationControlMember2022-01-012022-07-020001101302country:JPentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-07-020001101302country:JPentg:MicrocontaminationControlMember2022-01-012022-10-010001101302country:JPentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-10-010001101302country:JPentg:IntersegmentSalesEliminationMember2022-01-012022-10-010001101302country:JP2022-01-012022-07-020001101302country:JP2022-01-012022-10-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembersrt:EuropeMember2022-01-012022-10-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMembersrt:EuropeMember2022-01-012022-07-020001101302entg:AdvancedPlanarizationSolutionsMembersrt:EuropeMember2022-01-012022-10-010001101302entg:AdvancedPlanarizationSolutionsMembersrt:EuropeMember2022-01-012022-07-020001101302entg:MicrocontaminationControlMembersrt:EuropeMember2022-01-012022-10-010001101302entg:MicrocontaminationControlMembersrt:EuropeMember2022-01-012022-07-020001101302srt:EuropeMemberentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-07-020001101302srt:EuropeMemberentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-10-010001101302entg:IntersegmentSalesEliminationMembersrt:EuropeMember2022-01-012022-10-010001101302srt:EuropeMember2022-01-012022-10-010001101302srt:EuropeMember2022-01-012022-07-020001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMemberentg:SoutheastAsiaMember2022-01-012022-10-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMemberentg:SoutheastAsiaMember2022-01-012022-07-020001101302entg:AdvancedPlanarizationSolutionsMemberentg:SoutheastAsiaMember2022-01-012022-10-010001101302entg:AdvancedPlanarizationSolutionsMemberentg:SoutheastAsiaMember2022-01-012022-07-020001101302entg:MicrocontaminationControlMemberentg:SoutheastAsiaMember2022-01-012022-10-010001101302entg:MicrocontaminationControlMemberentg:SoutheastAsiaMember2022-01-012022-07-020001101302entg:SoutheastAsiaMemberentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-07-020001101302entg:SoutheastAsiaMemberentg:AdvancedMaterialsHandlingAMHMember2022-01-012022-10-010001101302entg:IntersegmentSalesEliminationMemberentg:SoutheastAsiaMember2022-01-012022-10-010001101302entg:SoutheastAsiaMember2022-01-012022-07-020001101302entg:SoutheastAsiaMember2022-01-012022-10-010001101302entg:SpecialtyChemicalsandElectronicMaterialsSCEMMember2022-01-012022-10-010001101302entg:AdvancedPlanarizationSolutionsMember2022-01-012022-10-010001101302entg:MicrocontaminationControlMember2022-01-012022-10-010001101302entg:AdvancedMaterialsHandlingAMHMember2022-01-012022-10-010001101302entg:IntersegmentSalesEliminationMember2022-01-012022-10-010001101302us-gaap:SubsequentEventMember2023-08-232023-08-23
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________________________________
FORM 10-Q
______________________________________________
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended July 1, 2023
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission file number: 001-32598
https://cdn.kscope.io/5737a6609a1400bd1f96c2a963e3b85b-Cropped Entegris Logo.jpg
_______________________________________
Entegris, Inc.
(Exact name of registrant as specified in its charter)
 _________________________________________
Delaware 41-1941551
(State or other jurisdiction of
incorporation or organization)
 (I.R.S. Employer
Identification No.)
129 Concord Road,Billerica,Massachusetts 01821
(Address of principal executive offices) (Zip Code)
(978) 436-6500
(Registrant’s telephone number, including area code)
None
(Former name, former address and former fiscal year, if changed since last report)
 _______________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $0.01 par value per shareENTGThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ý    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ýAccelerated filer 
Non-accelerated filer ¨Smaller reporting company 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No ý
As of July 31, 2023, there were 150,108,285 shares of the registrant’s common stock outstanding.



Table of Contents
ENTEGRIS, INC. AND SUBSIDIARIES
FORM 10-Q
TABLE OF CONTENTS
FOR THE QUARTER ENDED JULY 1, 2023
DescriptionPage
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Cautionary Statements
This Quarterly Report on Form 10-Q contains “forward-looking statements.” The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements may include statements about supply chain matters; inflationary pressures; future period guidance or projections; the Company’s performance relative to its markets, including the drivers of such performance; market and technology trends, including the duration and drivers of any growth trends; the development of new products and the success of their introductions; the focus of the Company’s engineering, research and development projects; the Company’s ability to execute on our business strategies, including with respect to Company’s expansion of its manufacturing presence in Taiwan and in Colorado Springs; the Company’s capital allocation strategy, which may be modified at any time for any reason, including share repurchases, dividends, debt repayments and potential acquisitions; the impact of the acquisitions the Company has made and commercial partnerships the Company has established, including the acquisition of CMC Materials, Inc. (now known as CMC Materials LLC) (“CMC Materials”); the closing of any announced divestitures and the termination of strategic partnerships, including the timing thereof; trends relating to the fluctuation of currency exchange rates; future capital and other expenditures, including estimates thereof; the Company’s expected tax rate; the impact, financial or otherwise, of any organizational changes; the impact of accounting pronouncements; quantitative and qualitative disclosures about market risk; and other matters. These forward-looking statements are based on current management expectations and assumptions only as of the date of this Quarterly Report, are not guarantees of future performance and involve substantial risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, but are not limited to, weakening of global and/or regional economic conditions, generally or specifically in the semiconductor industry, which could decrease the demand for the Company’s products and solutions; the level of, and obligations associated with, the Company’s indebtedness, including the debts incurred in connection with the acquisition of CMC Materials; risks related to the acquisition and integration of CMC Materials, including unanticipated difficulties or expenditures relating thereto, the ability to achieve the anticipated synergies and value-creation contemplated by the acquisition of CMC Materials and the diversion of management time on transaction-related matters; raw material shortages, supply and labor constraints, price increases, inflationary pressures and rising interest rates; operational, political and legal risks of the Company’s international operations; the Company’s dependence on sole source and limited source suppliers; the Company’s
2

Table of Contents
ability to meet rapid demand shifts; the Company’s ability to continue technological innovation and introduce new products to meet customers’ rapidly changing requirements; substantial competition; the Company’s concentrated customer base; the Company’s ability to identify, complete and integrate acquisitions, joint ventures, divestitures or other similar transactions; the Company’s ability to consummate pending transactions on a timely basis or at all and the satisfaction of the conditions precedent to consummation of such pending transactions, including the satisfaction of regulatory conditions on the terms expected, at all or in a timely manner; the Company’s ability to effectively implement any organizational changes; the Company’s ability to protect and enforce intellectual property rights; the ongoing conflict in Ukraine and the global response thereto; the increasing complexity of certain manufacturing processes; changes in government regulations of the countries in which the Company operates, including the imposition of tariffs, export controls and other trade laws and restrictions and changes to national security and international trade policy, especially as they relate to China; fluctuation of currency exchange rates; fluctuations in the market price of the Company’s stock; and other risk factors and additional information described in the Company’s filings with the Securities and Exchange Commission (the “SEC”), including under the heading “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed on February 23, 2023, and in the Company’s other SEC filings. Except as required under the federal securities laws and the rules and regulations of the SEC, the Company undertakes no obligation to update publicly any forward-looking statements or information contained herein, which speak as of their respective dates.
3

Table of Contents
PART 1.    FINANCIAL INFORMATION
Item 1. Financial Statements

ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited) 
(In thousands, except share and per share data)July 1, 2023December 31, 2022
ASSETS
Current assets:
Cash and cash equivalents$565,878 $561,559 
Restricted cash1,139 1,880 
Trade accounts and notes receivable, net of allowance for credit losses of $4,384 and $5,443
435,973 535,485 
Inventories, net740,351 812,815 
Deferred tax charges and refundable income taxes55,461 47,618 
Assets held-for-sale1,051,947 246,531 
Other current assets117,799 129,297 
Total current assets2,968,548 2,335,185 
Property, plant and equipment, net of accumulated depreciation of $830,906 and $770,093
1,364,760 1,393,337 
Other assets:
Right-of-use assets81,048 94,940 
Goodwill3,970,247 4,408,331 
Intangible assets, net of accumulated amortization of $720,336 and $636,872
1,421,710 1,841,955 
Deferred tax assets and other noncurrent tax assets66,682 28,867 
Other40,029 36,242 
Total assets$9,913,024 $10,138,857 
LIABILITIES AND EQUITY
Current liabilities:
Short-term debt, including current portion of long-term debt$ $151,965 
Accounts payable132,157 172,488 
Accrued payroll and related benefits92,994 142,340 
Accrued interest payable24,939 25,571 
Liabilities held-for-sale115,784 10,637 
Other accrued liabilities193,851 160,873 
Income taxes payable86,564 98,057 
Total current liabilities646,289 761,931 
Long-term debt, excluding current maturities, net of unamortized discount and debt issuance costs of $121,488 and $140,107
5,492,011 5,632,928 
Pension benefit obligations and other liabilities52,046 54,090 
Deferred tax liabilities and other noncurrent tax liabilities301,068 391,192 
Long-term lease liability69,405 80,716 
Equity:
Preferred stock, par value $.01; 5,000,000 shares authorized; none issued and outstanding as of July 1, 2023 and December 31, 2022
  
Common stock, par value $.01; 400,000,000 shares authorized; issued and outstanding shares as of July 1, 2023: 150,308,245 and 150,105,845, respectively; issued and outstanding shares as of December 31, 2022: 149,339,486 and 149,137,086, respectively
1,503 1,493 
Treasury stock, at cost: 202,400 shares held as of July 1, 2023 and December 31, 2022
(7,112)(7,112)
Additional paid-in capital2,274,572 2,205,325 
Retained earnings 1,110,818 1,031,391 
Accumulated other comprehensive loss(27,576)(13,097)
Total equity3,352,205 3,218,000 
Total liabilities and equity$9,913,024 $10,138,857 
See the accompanying notes to condensed consolidated financial statements.
4

Table of Contents

ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 
 Three months endedSix months ended
(In thousands, except per share data)July 1, 2023July 2, 2022July 1, 2023July 2, 2022
Net sales$901,000 $692,489 $1,823,396 $1,342,135 
Cost of sales516,834 382,092 1,037,545 721,918 
Gross profit384,166 310,397 785,851 620,217 
Selling, general and administrative expenses145,596 90,685 315,463 177,793 
Engineering, research and development expenses71,030 49,248 142,936 95,963 
Amortization of intangible assets54,680 12,494 112,254 25,145 
Goodwill impairment  88,872  
Gain on termination of alliance agreement(154,754) (154,754) 
Operating income267,614 157,970 281,080 321,316 
Interest expense80,908 32,001 167,054 44,877 
Interest income(2,303)(658)(3,628)(670)
Other expense, net7,724 9,619 3,066 14,521 
Income before income tax (benefit) expense 181,285 117,008 114,588 262,588 
Income tax (benefit) expense(16,491)17,517 4,978 37,392 
Equity in net loss of affiliates130  130  
Net income $197,646 $99,491 $109,480 $225,196 
Basic earnings per common share$1.32 $0.73 $0.73 $1.66 
Diluted earnings per common share$1.31 $0.73 $0.73 $1.65 
Weighted shares outstanding:
Basic149,825135,895149,626135,783
Diluted150,837136,454150,609136,503
See the accompanying notes to condensed consolidated financial statements.

5

Table of Contents
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
 
 Three months endedSix months ended
(In thousands)July 1, 2023July 2, 2022July 1, 2023July 2, 2022
Net income$197,646 $99,491 $109,480 $225,196 
Other comprehensive (loss) income, net of tax
Foreign currency translation adjustments(38,011)(9,014)(14,277)(11,142)
Pension liability adjustments  37 73 
Interest rate swap - cash flow hedge, change in fair value - income (loss), net of tax expense (benefit) of $2,834 and $(69) for the three and six months ended, respectively.
9,716  (239) 
Other comprehensive (loss) income(28,295)(9,014)(14,479)(11,069)
Comprehensive income $169,351 $90,477 $95,001 $214,127 
See the accompanying notes to condensed consolidated financial statements.

6

Table of Contents
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(Unaudited)
(In thousands)Common
shares
outstanding
Common
stock
Treasury sharesTreasury stockAdditional
paid-in
capital
Retained earnings Foreign currency translation adjustmentsDefined benefit pension adjustmentsInterest Rate Swap - Cash flow hedgeTotal
Balance at December 31, 2021135,719 $1,357 202 $(7,112)$879,845 $879,776 $(38,863)$(1,222)$ $1,713,781 
Shares issued under stock plans366 4 —  (12,742)    (12,738)
Share-based compensation expense—  —  9,285     9,285 
Dividends declared ($0.10 per share)
—  —   (13,660)   (13,660)
Pension liability adjustment—  —     73  73 
Foreign currency translation—  —    (2,128)  (2,128)
Net income—  —   125,705    125,705 
Balance at April 2, 2022136,085 1,361 202 (7,112)876,388 991,821 (40,991)(1,149) 1,820,318 
Shares issued under stock plans88 1  5,397     5,398 
Share-based compensation expense—  —  10,182     10,182 
Dividends declared ($0.10 per share)
—  —   (13,661)   (13,661)
Foreign currency translation—  —    (9,014)  (9,014)
Net income—  —   99,491    99,491 
Balance at July 2, 2022136,173 $1,362 202 $(7,112)$891,967 $1,077,651 $(50,005)$(1,149) $1,912,714 
(In thousands)Common
shares
outstanding
Common
stock
Treasury sharesTreasury stockAdditional
paid-in
capital
Retained earnings Foreign currency translation adjustmentsDefined benefit pension adjustmentsInterest Rate Swap - Cash flow hedgeTotal
Balance at December 31, 2022149,339 $1,493 202 $(7,112)$2,205,325 $1,031,391 $(49,083)$(83)$36,069 $3,218,000 
Shares issued under stock plans530 6 —  8,981     8,987 
Share-based compensation expense—  —  30,678     30,678 
Dividends declared ($0.10 per share)
—  —   (15,092)   (15,092)
Interest Rate Swap - Cash flow hedge—  —      (9,955)(9,955)
Pension liability adjustment—  —     37  37 
Foreign currency translation—  —    23,734   23,734 
Net loss—  —   (88,166)   (88,166)
Balance at April 1, 2023149,869 1,499 202 (7,112)2,244,984 928,133 (25,349)(46)26,114 3,168,223 
Shares issued under stock plans439 4 —  18,130     18,134 
Share-based compensation expense—  —  11,458     11,458 
Dividends declared ($0.10 per share)
— —   (14,961)   (14,961)
Interest Rate Swap - Cash flow hedge— —      9,716 9,716 
Foreign currency translation— —    (38,011)  (38,011)
Net Income— —   197,646    197,646 
Balance at July 1, 2023150,308 $1,503 202 $(7,112)$2,274,572 $1,110,818 $(63,360)$(46)$35,830 $3,352,205 
See the accompanying notes to condensed consolidated financial statements.
7

Table of Contents
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
 Six months ended
(In thousands)July 1, 2023July 2, 2022
Operating activities:
Net income $109,480 $225,196 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation90,494 48,286 
Amortization112,254 25,145 
Share-based compensation expense42,136 19,467 
Provision for deferred income taxes(66,814)(23,472)
Impairment of goodwill88,872  
Loss on extinguishment of debt 7,269  
Loss from sale of business and held-for-sale28,577  
Gain on termination of alliance agreement(154,754) 
Charge for excess and obsolete inventory23,287 13,916 
Other26,239 18,243 
Changes in operating assets and liabilities:
Trade accounts and notes receivable17,941 (57,309)
Inventories(5,009)(124,941)
Accounts payable and accrued liabilities(23,595)27,145 
Other current assets(1,534)(2,592)
Income taxes payable and refundable income taxes(15,570)(3,548)
Other(384)9,162 
Net cash provided by operating activities278,889 174,698 
Investing activities:
Acquisition of property, plant and equipment(250,043)(192,097)
Proceeds from sale of business
134,286  
Proceeds from termination of alliance agreement169,251  
Other366 1,123 
Net cash provided by (used in) investing activities53,860 (190,974)
Financing activities:
Proceeds from revolving credit facility and short-term debt 201,000 
Payments of revolving credit facility and short-term debt(135,000)(193,000)
Proceeds from long-term debt117,170 2,405,314 
Payments of long-term debt(293,671) 
Payments for debt issuance costs(3,475)(10,579)
Payments for dividends(30,150)(27,484)
Issuance of common stock36,767 8,977 
Taxes paid related to net share settlement of equity awards(9,646)(16,317)
Other(578)(587)
Net cash (used in) provided by financing activities(318,583)2,367,324 
Effect of exchange rate changes on cash, cash equivalents and restricted cash(10,588)(10,382)
Increase in cash, cash equivalents and restricted cash3,578 2,340,666 
Cash, cash equivalents and restricted cash at beginning of period563,439 402,565 
Cash, cash equivalents and restricted cash at end of period$567,017 $2,743,231 
     See the accompanying notes to condensed consolidated financial statements.
8

Table of Contents
ENTEGRIS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
(Unaudited)
Supplemental Cash Flow InformationSix months ended
(unaudited)
(In thousands)July 1, 2023July 2, 2022
Non-cash transactions:
       Original issue discount credit due from lender$ $65,389 
Equipment purchases in accounts payable22,607 23,394 
Dividend payable557 495 
Schedule of interest and income taxes paid:
Interest paid less capitalized interest260,282 15,699 
Income taxes paid, net of refunds received85,913 62,168 
See the accompanying notes to condensed consolidated financial statements.
9

Table of Contents
ENTEGRIS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations Entegris, Inc. (“Entegris”, “the Company”, “us”, “we”, or “our”) is a leading supplier of advanced materials and process solutions for the semiconductor and other high-technology industries.
Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. Intercompany profits, transactions and balances have been eliminated in consolidation.
Use of Estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, particularly receivables, inventories, property, plant and equipment, right-of-use assets, goodwill, intangibles, accrued expenses, short-term and long-term lease liability, income taxes and related accounts, and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Basis of Presentation The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States and contain all adjustments considered necessary, and are of a normal recurring nature, to present fairly the financial position as of July 1, 2023 and December 31, 2022, and the results of operations and comprehensive income for the three and six months ended July 1, 2023 and July 2, 2022, the equity statements as of and for the three and six months ended July 1, 2023 and July 2, 2022, and cash flows for the six months ended July 1, 2023 and July 2, 2022.
Our recently acquired subsidiary, CMC Materials LLC (formerly known as CMC Materials, Inc.) (“CMC Materials”), follows a monthly reporting calendar. The second quarter of 2023 for CMC Materials ended on June 30, 2023, whereas the Company’s second quarter ended on July 1, 2023. The Company believes that use of the different fiscal periods for this entity has not had a material impact on the Company’s condensed consolidated financial position, results of operations, or liquidity. All significant intercompany balances and transactions have been eliminated in consolidation.
The condensed consolidated financial statements and accompanying notes are presented as permitted by Form 10-Q and do not contain certain information included in the Company’s annual consolidated financial statements and notes. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with Management’s Discussion and Analysis and consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The results of operations for the three and six months ended July 1, 2023 are not necessarily indicative of the results to be expected for the full year.
Recently Adopted Accounting Pronouncements The Company currently has no material recently adopted accounting pronouncements.
Recently Issued Accounting Pronouncements The Company currently has no material recent accounting pronouncements yet to be adopted.

10

Table of Contents
2. REVENUES
The following table provides information about current contract liabilities from contracts with customers. The contract liabilities are included in other accrued liabilities balance in the condensed consolidated balance sheet.
(In thousands)July 1, 2023July 2, 2022
Balance at beginning of period$60,476 $23,050 
Revenue recognized that was included in the contract liability balance at the beginning of the period(43,905)(15,585)
Increases due to cash received, excluding amounts recognized as revenue during the period
79,621 25,770 
Contract liabilities included as part of disposition(6,226) 
Balance at end of period$89,966 $33,235 

3. GOODWILL IMPAIRMENT
During the first quarter of 2023, while the criteria had not been met to classify the reporting unit as held for sale, the Company was exploring market interest in a potential sale of the Electronic Chemicals (“EC”) reporting unit within the Advanced Planarization Solutions segment. In connection with the sale process, management determined that certain impairment indicators were present and evaluated goodwill, intangible assets, and long-lived assets for impairment in connection with the quarter ending April 1, 2023.

Long-lived assets, including finite-lived intangible assets
The Company compared the estimated undiscounted future cash flows generated by the asset group to the carrying amount of the asset group for the reporting unit and determined that the undiscounted cash flows are expected to exceed the carrying value on a held and used basis, therefore no impairment was recorded on the long-lived asset or finite-lived intangible assets. The Company considered if the triggering event would cause a potential change to the useful life of the assets and did not consider a modification to the useful life necessary.

Goodwill
The Company compared the reporting unit’s fair value to its carrying amount, including goodwill as of April 1, 2023. As the reporting unit’s carrying amount, including goodwill, exceeded its fair value, the Company determined the goodwill was impaired and recorded an impairment of $88.9 million during the first quarter of 2023. The impairment is classified as goodwill impairment in the Company's condensed consolidated statement of operations. The goodwill impairment is non-taxable. The fair value of the reporting unit was determined using a market-based approach, which was aligned to the expected selling price of approximately $700.0 million. We consider this a Level 3 measurement in the fair value hierarchy.

During the second quarter of 2023, the EC reporting unit met the classification for held for sale, see Note 5. There was no goodwill impairment related to the EC reporting unit in the second quarter of 2023.

4. ACQUISITION
CMC Materials
On July 6, 2022 (the “Closing Date”), the Company completed its acquisition of CMC Materials for approximately $6.0 billion in cash and stock (the “Acquisition”) pursuant to an Agreement and Plan of Merger dated as of December 14, 2021 (the “Acquisition Agreement”). As a result of the Acquisition, CMC Materials became a wholly owned subsidiary of the Company. The Acquisition was accounted for under the acquisition method of accounting and the results of operations of CMC Materials are included in the Company's condensed consolidated financial statements as of and since July 6, 2022. CMC Materials reports into the Advanced Planarization Solutions and Specialty Chemicals and Engineered Materials segments of the Company. Direct costs of $39.5 million associated with the acquisition of CMC Materials, consisting primarily of professional and consulting fees, were expensed as incurred in fiscal year 2022. These costs are classified as selling, general and administrative expense in the Company's condensed consolidated statement of operations.

CMC Materials is a global supplier of consumable materials, primarily to semiconductor manufacturers. The Company's products play a critical role in the production of advanced semiconductor devices, helping to enable the manufacture of smaller, faster and more complex devices by its customers. The acquisition broadened the Company’s solutions set and enables the Company to bring to market a broader array of innovative and high-value solutions, at a faster pace, to help customers improve productivity, performance and total cost of ownership.
11

Table of Contents
The purchase price of CMC Materials consisted of the following:

(In thousands):
Cash paid to CMC Materials’ shareholders$3,836,983 
Stock paid to CMC Materials’ shareholders1,265,690 
Repayment of CMC Materials’ indebtedness918,578 
Total purchase price6,021,251 
Less cash and cash equivalents acquired280,636 
Total purchase price, net of cash acquired$5,740,615 

Under the terms of the Acquisition Agreement, the Company paid $133.00 per share for all outstanding shares of CMC Materials (excluding treasury shares). In addition, the Company settled all outstanding share-based compensation awards held by CMC Materials’ employees at the same per share price except for certain unvested performance units that were replaced by the Company’s restricted share units. The acquisition method of accounting requires the Company to include the amount associated with pre-combination service as purchase price for the acquisition, reflected in the table immediately above.

The Acquisition was funded with existing cash balances as well as funds raised by the Company through the issuance of debt in the form of a new term loan facility in the aggregate principal amount of $2,495.0 million, senior secured notes due 2029 in an aggregate principal amount of $1,600.0 million, senior unsecured notes due 2030 in an aggregate principal amount of $895.0 million, and a 364-Day Bridge Credit Facility in the aggregate principal amount of $275.0 million.

The following table summarizes the allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed at the date of the Acquisition:

(In thousands):July 6, 2022
Cash and cash equivalents$280,636 
Accounts receivable and other current assets207,472 
Inventory256,598 
Property, plant and equipment537,387 
Identifiable intangible assets1,736,219 
Other noncurrent assets39,725 
Current liabilities(211,417)
Deferred tax liabilities and other noncurrent liabilities(452,805)
Net assets acquired2,393,815 
Goodwill3,627,436 
Total purchase price$6,021,251 

The final valuation of assets acquired and liabilities assumed in connection with the Acquisition was completed in the second quarter of 2023.

The fair value of acquired inventories was $256.6 million and was valued at the estimated selling price less the cost of disposal and reasonable profit for the selling effort. The fair value write-up of acquired finished goods inventory was $61.9 million. This amount was recorded as an incremental cost of sales charge, amortized over the expected turn of the acquired inventory, during the year ended December 31, 2022.
The fair value of acquired property, plant and equipment of $537.4 million is valued at its fair value assuming held and used,
unless market data was available supporting the fair value.
The Company recognized the following intangible assets as part of the acquisition of CMC Materials and finite-lived assets are amortized on a straight-line basis:
12

Table of Contents
(In thousands)AmountWeighted
average life in
years
Developed technology$1,043,000 7.3
Trademarks and trade names236,600 14.9
Customer relationships414,300 18.3
In-process research and development (1)
31,400 
Other10,919 1.0
$1,736,219 11.0

(1) In-process research and development assets are treated as indefinite-lived until the completion or abandonment of the associated research and development project, at which time the appropriate useful lives would be determined.

The fair value of acquired identifiable finite intangible assets was determined using an income method, which utilizes discounted cash flows to identify the fair value of each of the identifiable intangible assets. The Company normally utilizes the “income method,” which starts with a forecast of all of the expected future net cash flows attributable to the subject intangible asset. These cash flows are then adjusted to present value by applying an appropriate discount rate that reflects the risk factors associated with the cash flow streams. Depending on the asset valued, the key assumptions included one or more of the following: (1) future revenue growth rates, (2) future gross margin, (3) future selling, general and administrative expenses, (4) royalty rates, and (5) discount rates. The valuations were based on the information that was available as of the acquisition date and the expectations and assumptions that have been deemed reasonable by the Company’s management. There are inherent uncertainties and management judgment required in these determinations. The fair value measurements of the assets acquired and liabilities assumed were based on valuations involving significant unobservable inputs, or Level 3 in the fair value hierarchy.

The purchase price of CMC Materials exceeded the fair value of the net of the acquisition-date amounts of the identifiable assets acquired and the liabilities assumed by $3,627.4 million. Cash flows used to determine the purchase price included strategic and synergistic benefits (investment value) specific to the Company, which resulted in a purchase price in excess of the fair value of identifiable net assets. The purchase price also included the fair values of other assets that were not identifiable, not separately recognizable under accounting rules (e.g., assembled workforce) or of immaterial value in addition to a going-concern element that represents the Company's ability to earn a higher rate of return on the group of assets than would be expected on the separate assets as determined during the valuation process. This additional investment value resulted in goodwill. No amount of goodwill is expected to be deductible for tax purposes.

Pro Forma Results (Unaudited)
The following unaudited pro forma financial information presents the combined results of operations of the Company as if the acquisition of CMC Materials had occurred January 1, 2021. The unaudited pro forma financial information is not necessarily indicative of what the Company’s condensed consolidated results of operations actually would have been had the acquisition occurred at the beginning of each year. In addition, the unaudited pro forma financial information does not attempt to project the future results of operations of the combined company. The pro forma information does not include any potential revenue enhancements, cost synergies or other operating efficiencies that could result from the acquisition.

 Three months endedSix months ended
(In thousands, except share data)July 2, 2022July 2, 2022
Net sales$1,011,862 $1,980,953 
Net income70,417 170,681 
Per share amounts:
Net income per common share - basic$0.47 $1.15 
Net income per common share - diluted$0.47 $1.13 

The unaudited pro forma financial information above gives effect to the following:

13

Table of Contents
The elimination of transactions between Entegris and CMC Materials, which upon completion of the Acquisition would be considered intercompany. This reflects the elimination of intercompany sales and associated intercompany accounts.
Incremental amortization and depreciation expense related to the estimated fair value of identifiable intangible assets and property, plant and equipment from the purchase price allocation.
Interest expense on the new debt raised to fund in part the consideration paid to effect the Acquisition using the effective interest rates.
The elimination of interest expense associated with the repayment of the $145.0 million senior secured term loan facility due 2025.
The amortization of deferred financing costs and original issue discount associated with the aggregate new debt facilities.
Transaction and integration costs directly attributable to the Acquisition were reclassed as of the beginning of the comparable prior annual reporting period.
The income tax effect of the transaction accounting adjustments related to the Acquisition calculated using a blended statutory income tax rate of 22.5%.
5. ASSET HELD-FOR-SALE AND DIVESTITURE

Asset Held-For-Sale - PIM

On October 11, 2022, the Company announced entry into a definitive agreement to sell its Pipeline and Industrials Materials (“PIM”) business, which became part of the Company with the acquisition of CMC Materials, to Infineum USA L.P. (“Infineum”). The PIM business specializes in the manufacture and sale of drag reducing agents and a range of valve maintenance products and services, and reports into the Specialty Chemicals and Engineered Materials segment of the Company. Effective February 10, 2023, the Company terminated the definitive agreement. In accordance with the terms of the agreement, the Company received a $12.0 million termination fee from Infineum in the first quarter of 2023 and incurred a transaction adviser fee of $1.1 million. The net amount of $10.9 million is recorded in Other expense, net in the condensed consolidated statement of operations. At the time of the termination, the transaction had not received clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”).

During the fourth quarter of 2022, the related assets and liabilities were classified as held-for-sale in the Company’s consolidated balance sheet and measured at the lower of their carrying amount or fair value less cost to sell. The assets and liabilities continue to be classified as held-for-sale at July 1, 2023.

The planned disposition of the PIM business did not meet the criteria to be classified as a discontinued operation in the Company’s financial statements since the disposition did not represent a strategic shift that had, or will have, a major effect on the Company’s operations and financial results.

PIM Assets-held-for sale comprise the following as of July 1, 2023:
(In thousands)
Assets:July 1, 2023
Current assets$51,612 
Property, Plant and Equipment, net110,944 
Intangible assets, net76,692 
Goodwill12,707 
Other assets1,352 
Total assets-held-for sale$253,307 
Liabilities:
Accounts payable$6,628 
Accrued expenses6,584 
Long-term liabilities1,235 
Total liabilities-held-for sale$14,447 

14

Table of Contents
Income before income taxes attributable to the PIM business was $12.7 million and $21.3 million for the three and six months ended July 1, 2023, respectively.

Asset held-for-sale - EC Business

On May 10, 2023, the Company announced entry into a definitive agreement to sell its Electronic Chemicals (“EC”) business, which became part of the Company with the acquisition of CMC Materials, to FUJIFILMS Holdings America Corporation for $700.0 million, subject to customary adjustments with respect to cash, working capital, indebtedness and transaction expenses. The EC business specializes in purification, formulation, blending, packaging and distribution of high-purity process chemicals used within the semiconductor and microelectronic manufacturing processes. The divestiture is currently expected to close before the end of 2023, subject to receipt of required regulatory approvals and other customary closing conditions. The EC business reports into the Advanced Planarization Solutions segment of the Company. The Company recognized a loss on the assets held-for-sale of $13.6 million on the sale for the EC business for the three and six months ended July 1, 2023. The loss is included in Selling, general and administrative expenses in the condensed consolidated statement of operations.

The planned disposition of the EC business did not meet the criteria to be classified as a discontinued operation in the Company’s financial statements since the disposition did not represent a strategic shift that had, or will have, a major effect on the Company’s operations and financial results.

EC Assets-held-for sale comprise the following as of July 1, 2023:
(In thousands)
Assets:July 1, 2023
Current assets$106,063 
Property, Plant and Equipment, net170,180 
Intangible assets, net263,686 
Goodwill250,775 
Other assets7,936 
Total assets-held-for sale$798,640 
Liabilities:
Accounts payable$16,706 
Accrued expenses14,449 
Long-term liabilities70,182 
Total liabilities-held-for sale$101,337 

Loss before income taxes attributable to the EC business was $3.1 million and $86.6 million for the three and six months ended July 1, 2023. The loss before income taxes attributed to the EC business for the three and six months ended July 1, 2023 included the $13.6 million loss on held for sale as noted above and the six months ended included the $88.9 million goodwill impairment, see Note 5.

Divestiture - QED

During the first quarter of 2023, the Company announced entry into a definitive agreement to sell QED Technologies International, Inc. (“QED”), which offers magnetorheological finishing polishing and subaperture stitching interferometry metrology manufacturing solutions. to Quad-C Management, Inc. QED was a part of the Specialty Chemicals and Engineered Materials segment and became part of the Company with the acquisition of CMC Materials.

The Company completed the divestiture of QED on March 1, 2023 and received proceeds of $134.3 million after adjustments with respect to cash, working capital, indebtedness and transaction expenses. The disposition of QED did not meet the criteria to be classified as a discontinued operation in the Company’s financial statements since the disposition did not represent a strategic shift that had a major effect on the Company’s operations and financial results. The following table summarizes the fair value of the sale proceeds received in connection with the divestiture, which are subject to further post-closing adjustment:

15

Table of Contents
(In thousands)March 1, 2023
Fair value of sale consideration$137,500 
Final working capital adjustment 1,031 
Cash transferred to the buyer on the closing balance sheet(1,465)
Direct costs to sell(2,780)
   Fair value of sale consideration$134,286 

The carrying amount of net assets associated with the QED business was approximately $149.2 million. The major classes of assets and liabilities sold consisted of the following:

(In thousands)March 1, 2023
Assets:
Current assets$19,219 
Property, plant and equipment, net2,663 
Goodwill90,005 
Intangible assets, net48,661 
Other assets842 
  Total assets$161,390 
Liabilities:
Accounts payable$1,340 
Accrued expenses8,750 
Long-term liabilities2,067 
  Total liabilities$12,157 
As a result of the QED divestiture, the Company recognized a pre-tax loss of $1.3 million and $14.9 million presented in selling, general and administrative expenses on the condensed consolidated statements of operations for the three and six months ended July 1, 2023, respectively. The Company recorded an income tax benefit associated with the QED divestiture of approximately $6.8 million.

Termination - Alliance Agreement

On June 5, 2023, the Company announced the termination of an Alliance Agreement (the “Alliance Agreement”) between the Company and MacDermid Enthone Inc., a global business unit of Element Solutions Inc (“MacDermid Enthone”). Under the Alliance Agreement, Entegris had been granted the exclusive right to distribute MacDermid Enthone's Viaform products, subject to certain conditions. In connection with the termination of the Alliance Agreement, Entegris will receive a payment of $200.0 million, subject to certain adjustments, with $170.0 million that was paid on June 2, 2023 upon the termination of the alliance agreement and $30.0 million payable upon completion of customer transitions. The Company recognized a pre-tax gain of $154.8 million presented in gain on termination of alliance agreement on the condensed consolidated statements of operations for the three and six months ended July 1, 2023.
16

Table of Contents
6. RESTRICTED CASH
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheet that sum to the total of the same amounts shown in the condensed consolidated statement of cash flows.
(In thousands)July 1, 2023December 31, 2022
Cash and cash equivalents$565,878 $561,559 
Restricted cash1,139 1,880 
Total cash, cash equivalents and restricted cash$567,017 $563,439 
The restricted cash represents cash held in a “Rabbi” trust. Prior to the acquisition of CMC Materials, CMC Materials’ change in control severance protection agreements required CMC Materials to establish a Rabbi trust prior to a change in control and fully fund the trust to cover all the severance benefits that may become payable under the agreements.
7. INVENTORIES
Inventories consist of the following:
 
(In thousands)July 1, 2023December 31, 2022
Raw materials$315,616 $337,576 
Work-in-process55,978 60,182 
Finished goods (1)
368,757 415,057 
Total inventories, net$740,351 $812,815 

(1) Includes consignment inventories held by customers of $23.9 million and $46.2 million at July 1, 2023 and December 31, 2022, respectively.

8. GOODWILL AND INTANGIBLE ASSETS
Goodwill activity for each of the Company’s reportable segments that carry goodwill, Specialty Chemicals and Engineered Materials (“SCEM”), Advanced Planarization Solutions (“APS”), Microcontamination Control (“MC”), and Advanced Materials Handling (“AMH”), and was as follows at December 31, 2022 and July 1 2023:
(In thousands)SCEMAPSMCAMHTotal
December 31, 2022$561,328 $3,530,813 $242,088 $74,102 $4,408,331 
Goodwill impairment (88,872)  (88,872)
Disposition of business(90,005)   (90,005)
Purchase accounting adjustments3,409 (4,430)  (1,021)
Assets held-for-sale(3,885)(250,775)  (254,660)
Foreign currency translation(33) (3,493) (3,526)
July 1, 2023$470,814 $3,186,736 $238,595 $74,102 $3,970,247 
The changes in our goodwill balance of $438.1 million reflect (1) the goodwill impairment of our EC reporting unit of $88.9 million, as described in Note 3, (2) the sale of the QED business and related goodwill of that business of $90.0 million, see Note 5, (3) purchase accounting adjustments of $1.0 million, (4) goodwill reclassified to asset held-for-sale of $254.7 million as described in Note 5 and (5) foreign currency translation of $3.5 million.
17

Table of Contents


Identifiable intangible assets at July 1, 2023 and December 31, 2022 consist of the following:
July 1, 2023
(In thousands)Gross carrying
amount
Accumulated
amortization
Net carrying
value
Developed technology$1,262,685 $384,845 $877,840 
Trademarks and trade names172,272 32,610 139,662 
Customer relationships673,765 282,644 391,121 
In-process research and development (1)
9,400  9,400 
Other23,924 20,237 3,687 
$2,142,046 $720,336 $1,421,710 
December 31, 2022
(In thousands)Gross carrying
amount
Accumulated
amortization
Net carrying
value
Developed technology$1,302,101 $313,876 $988,225 
Trademarks and trade names250,473 29,565 220,908 
Customer relationships863,947 273,039 590,908 
In-process research and development (1)
31,100  31,100 
Other31,206 20,392 10,814 
$2,478,827 $636,872 $1,841,955 
(1) Intangible assets acquired in a business combination that are in-process and used in research and development activities are considered indefinite-lived until the completion or abandonment of the research and development efforts. Once the research and development efforts are completed, we determine the useful life and begin amortizing the assets.
Future amortization expense relating to intangible assets currently recorded in the Company’s condensed consolidated balance sheets is estimated to be the following at July 1, 2023:
(In thousands)Remaining 20232024202520262027ThereafterTotal
Future amortization expense$102,710 194,774 188,318 185,381 181,694 568,833 $1,421,710 

18

Table of Contents


9. DEBT
The Company’s debt as of July 1, 2023 and December 31, 2022 consists of the following:
(In thousands)July 1, 2023December 31, 2022
Senior secured term loan facility due 20292,318,499 2,495,000 
Senior secured notes due 20291,600,000 1,600,000 
Senior unsecured notes due 2030895,000 895,000 
Senior unsecured notes due 2029400,000 400,000 
Senior unsecured notes due 2028400,000 400,000 
Bridge credit facility due 2023 135,000 
Revolving facility due 2027  
Total debt (par value)5,613,499 5,925,000 
Unamortized discount and debt issuance costs121,488 140,107 
Total debt, net$5,492,011 $5,784,893 
Less short-term debt, including current portion of long-term debt 151,965 
Total long-term debt, net$5,492,011 $5,632,928 
Annual maturities of long-term debt, excluding unamortized discount and debt issuance costs, due as of July 1, 2023 are as follows:
(In thousands)Remaining 20232024202520262027ThereafterTotal
Contractual debt obligation maturities(1)
$     5,613,499 $5,613,499 
(1) Subject to Excess Cash Flow payments to the lenders.
On March 10, 2023, the Company and certain of its subsidiaries entered into Amendment No. 1 (the “Amendment”) with the lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent, which amended the Credit and Guaranty Agreement, dated as of November 6, 2018 (as amended and restated as of July 6, 2022 and as further amended, restated, amended and restated, supplemented, modified and otherwise in effect prior to the effectiveness of the Amendment, the “Existing Credit Agreement” and, the Existing Credit Agreement as amended by the Amendment, the “Amended Credit Agreement”), by and among the Company, as borrower, certain subsidiaries of the Company party thereto, as guarantors, the lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent.
The Amendment provides for, among other things, the refinancing of the Company’s outstanding term B loans under the Existing Credit Agreement in an aggregate principal amount of $2.495 billion (the “Original Tranche B Term Loans”) with a new tranche of term B loans under the Amended Credit Agreement in an aggregate principal amount of $2.495 billion (the “New Tranche B Term Loans”). The New Tranche B Term Loans will bear interest under the Amended Credit Agreement at a rate per annum equal to, at the Company’s option, either (i) Term SOFR plus an applicable margin of 2.75% or (ii) a base rate plus an applicable margin of 1.75%. Consistent with the Original Tranche B Term Loans, the new Tranche B Term Loans will mature on July 6, 2029. Other than as described herein (and more fully described in the Amendment), the terms of the Amended Credit Agreement are substantially similar to the terms of the Existing Credit Agreement. Additionally, as of July 1, 2023, during the fiscal year 2023, the Company has repaid $176.5 million of the outstanding borrowings under the New Tranche B Term Loans. In connection with this repayment and entry into the Amendment, the Company incurred a pre-tax loss on extinguishment and modification of debt of $3.8 million and $7.6 million for the three and six months ended July 1, 2023, which is included in Other expense, net on the condensed consolidated statements of operations.

On April 20, 2023, the Company repaid the principal amount of the $135.0 million bridge credit facility. In connection with the repayment of this debt, the Company incurred a pre-tax loss on extinguishment of debt of $0.7 million for the three and six months ended July 1, 2023, which is included in Other expense, net on the condensed consolidated statements of operations.

10. FAIR VALUE OF FINANCIAL INSTRUMENTS
The Company is required to record certain assets and liabilities at fair value. The valuation methods used for determining the fair value of these financial instruments by hierarchy are as follows:
19

Table of Contents


Level 1 Cash and cash equivalents consist of various bank accounts used to support our operations and investments in institutional money-market funds that are traded in active markets. The restricted cash represents cash held in a “Rabbi” trust, further described in Note 6.
Level 2 Derivative financial instruments include an interest rate swap contract and foreign exchange contracts. The fair value of our derivative instruments is estimated using standard valuation models and market-based observable inputs over the contractual term, including the prevailing SOFR based yield curves for the interest rate swap, and forward rates and/or the Overnight Index Swap curve for forward foreign exchange contracts, among others.
Level 3 No Level 3 financial instruments.
The following table presents financial instruments, other than debt, that we measure at fair value on a recurring basis. See Note 9 of this Report on Form 10-Q for a discussion of our debt. In instances where the inputs used to measure the fair value of an asset fall into more than one level of the hierarchy, we have classified it based on the lowest level input that is significant to the determination of the fair value.
Fair Value Measurements at Reporting Date Using
(In thousands):Level 1Level 2Level 3Total
Assets:July 1, 2023December 31, 2022July 1, 2023December 31, 2022July 1, 2023December 31, 2022July 1, 2023December 31, 2022
Cash and cash equivalents$565,878 $561,559 $ $ $ $ $565,878 $561,559 
Restricted cash1,139 1,880     1,139 1,880 
Derivative financial instruments - Interest rate swap - cash flow hedge  46,281 46,589   46,281 46,589 
Derivative financial instruments -Forward exchange contracts— — — 726 — — — 726 
Total Assets$567,017 $563,439 $46,281 $47,315 $ $ $613,298 $610,754 
Liabilities:
Derivative financial instruments - Forward exchange contracts$— $— $—